Find Academic Supervisors

• Genetics
• Molecular Biology
• Virology
• +3 more

Cheng Luo is a Researcher in the Department of Computing and Mathematical Sciences. Their work focuses on interdisciplinary research at the intersection of molecular biology, genetics, and bioengineering. Key areas include AAV vector engineering for targeted gene therapy, piRNA pathway mechanisms in germline development, and SUMOylation-mediated gene regulation. They specialize in developing viral vectors for precise delivery to nervous system cell types and investigating epigenetic silencing processes in Drosophila. Research interests emphasize advancing gene therapy technologies through AAV capsid design, understanding RNA-guided silencing pathways (piRNA/SiRNA systems), and applying molecular engineering to address challenges in neurobiology and cancer immunology. Their contributions span virology, epigenetics, and developmental biology with applications in both fundamental science and translational medicine. Publications highlight advancements in AAV library construction, systemic delivery strategies, and mechanisms underlying transposon control. Work on SUMOylation pathways links molecular biology to chromatin dynamics, while studies on trogocytosis explore immunological applications. Though no awards or grants are explicitly listed, the volume and technical sophistication of their publications indicate active research engagement in high-impact areas.

Andrew HoldingView profile

Senior Lecturer

• Steroid Hormone Receptors
• Cancer Biology
• Genomics
• +4 more

Dr. Andrew Holding is a Senior Lecturer in Biomedical Science within the Department of Biology at the University of York. His research program centers on steroid hormone receptor dynamics across healthy tissues and cancer pathologies, with particular emphasis on glucocorticoid and estrogen receptors in breast cancer mechanisms. Methodologically, he employs CRISPR/Cas9 genome editing, single-cell RNA sequencing, and machine learning to characterize co-regulator proteins and their roles in treatment resistance. His core research examines: Cellular response mechanisms to steroid hormones Computational modeling of receptor interaction networks CRISPR-based functional genomics in cancer models Machine learning integration of multi-omics data Evolution of drug resistance in hormone-driven cancers Publications show consistent focus on chromatin dynamics, transcriptional regulation in cancer (particularly breast cancer and leukemia), and development of computational tools for genomic analysis. Recent work emphasizes hypoxia pathways, metabolic reprogramming in metastasis, and epigenetic drivers of tumor microenvironments. Active grants include: BBSRC IAA: Establishing tissue differentiation models of human breast epithelium MRC-funded project on sodium signaling in tumor hypoxia Deep learning integration of interactome data for protein-protein interaction prediction He leads laboratory investigations into steroid receptor co-regulators and maintains collaborations across computational biology and clinical oncology domains.

• Autism Genetics
• Psychiatry
• Child and Adolescent Psychiatry
• +3 more

Paul El-Fishawy is an Assistant Clinical Professor at the Yale Child Study Center, Yale School of Medicine. He holds dual degrees in Medicine (MD) and Law (J.D.) from Yale University. His clinical practice focuses on general child, adolescent, and adult psychiatry, emphasizing psychodynamic and cognitive behavioral therapies. He has been consistently recognized as a 'Best Doctor in America' since 2015 and is board-certified in both child/adolescent and adult psychiatry. Dr. El-Fishawy’s research centers on autism genetics, utilizing homozygosity mapping and whole-exome sequencing to identify contributing genes. His work has been supported by prestigious awards such as the APA-Lilly Research Fellowship and the Beatrix Hamburg Award. He has co-authored influential studies in Nature and Science . Education: AB (Magna Cum Laude, Phi Beta Kappa) from Princeton University (1992), JD from Yale Law School (2000), MD from Yale School of Medicine (2004). Recipient of the Lauren Weinstein Award for personal and professional excellence Recipient of the Melvin Lewis Teaching Award for medical student education He actively participates in academic governance, serving on the Executive Committee of the Connecticut Council on Child and Adolescent Psychiatry. His clinical and research contributions bridge psychiatry, genetics, and legal ethics, reflecting his interdisciplinary training.

Yang LiuView profile

Assistant Professor

• Spatial Omics
• Cancer Research
• Neurological Diseases
• +5 more

Yang Liu, PhD, is an Assistant Professor in the Department of Pathology at Yale School of Medicine. He specializes in developing spatial multi-omics technologies, including DBiT-seq and Spatial-CITE-seq, which enable high-resolution analysis of RNA, proteins, and epigenetic markers in tissues. His research focuses on applying these techniques to study tumor microenvironments, neurological diseases, cardiovascular disorders, and developmental biology. Dr. Liu holds a PhD in Environmental Toxicology from the University of California, Riverside, and has conducted postdoctoral research at Yale since 2018 under Dr. Rong Fan. Education: PhD, Environmental Toxicology, University of California, Riverside (2017) MS, Computer Science, University of California, Riverside (2017) MS, Analytical Chemistry, Chinese Academy of Sciences (2011) BS/BE, Computer Science & Environmental Engineering, Huazhong University of Science & Technology (2008) His lab develops cutting-edge spatial omics tools to address complex biological questions. Recent work includes studying the CD24-Siglec axis in inflammatory diseases and investigating integrin-mediated signaling in cardiovascular pathologies. Dr. Liu has received prestigious awards including the NIH HuBMAP Jumpstart Award and R35 MIRA grant. Awards: SITC-SU2C Convergence Scholar Award (2019) NIH HuBMAP Jumpstart Award (2021) R35 Maximizing Investigators' Research Award (202X) Collaborations with clinicians and engineers at Yale advance translational research, particularly in leveraging spatial omics for precision medicine. His lab seeks to recruit graduate students and postdocs passionate about interdisciplinary technology development.

• Structural Biology
• Molecular Genetics
• Plant Immunity
• +3 more

Eliza Martin is a Researcher affiliated with the Yale School of Medicine. Her work focuses on structural biology, molecular genetics, and computational methods applied to immunology and plant immunity. She has contributed to studies on RAG proteins, NLR receptors in plants, and the development of software tools like Robosample and NLRexpress. Her research often integrates machine learning and bioinformatics to address questions in protein function, evolution, and disease mechanisms. Key contributions include insights into V(D)J recombination, plant immune signaling pathways, and drug discovery for viral pathogens like SARS-CoV-2. Her interdisciplinary approach bridges computational modeling and experimental biology. Education details are not explicitly provided in the text, but her research trajectory suggests advanced training in molecular biology or biochemistry. She collaborates across disciplines, as evidenced by publications spanning structural biology, evolutionary genetics, and computational methods. Awards and grants are not listed here, but her active publication record indicates sustained research engagement.

Angus LamondView profile

Professor

• Proteomics
• RNA Processing
• Nuclear Biology
• +3 more

Angus Lamond is a Professor of Biochemistry in the Department of Molecular Cell and Developmental Biology. His research focuses on nuclear structure-function relationships, RNA processing mechanisms, and proteomic analysis of cellular systems. Key areas include subnuclear organelle composition, chemical biology tools for RNA regulation, and stem cell proteomics. Recent studies involve screening drug responses in iPSC cohorts, investigating mTORC3 assembly, and analyzing neutrophil proteomes post-SARS-CoV-2 infection. His work integrates mass spectrometry, microscopy, and deep sequencing to explore disease mechanisms related to nuclear organization. Lamond leads projects such as 'Characterising Splice Site Modulation for Huntington’s Disease' and collaborates with institutions like King’s College London. He has supervised 10 research works and contributed to initiatives like the HipSci consortium for iPSC proteomic analysis.

John Yates IIIView profile

Professor

• Proteomics
• Mass Spectrometry
• Genomic Sequencing
• +5 more

John Yates III is a Professor in the Department of Integrative Structural and Computational Biology at Scripps Research. He holds joint appointments in Neuroscience and the Skaggs Graduate School of Chemical and Biological Sciences. His research focuses on proteomics, leveraging mass spectrometry and genomic data to analyze complex protein mixtures and study diseases like malaria and anthrax. He has pioneered tools for identifying post-translational modifications in proteins. Education: Ph.D. (Chemistry), University of Virginia, 1987 M.S. (Chemistry), University of Maine, 1983 B.A. (Zoology), University of Maine, 1980 Research Interests: Dr. Yates' work integrates mass spectrometry with bioinformatics to address fundamental biological questions. His lab develops advanced proteomic strategies for analyzing protein complexes, host-pathogen interactions, and post-translational modifications. Applications span from purified protein studies to disease mechanisms in infectious diseases. Awards & Honors: 2021 ACS Award in Analytical Chemistry (Battelle Memorial Institute) 2019 John B. Fenn Award (ASMS) 2018 Thomson Medal (International Mass Spectrometry Society) 2015 Ralph N. Adams Award (Pittcon) 2013 #1 Most Influential in Analytical Chemistry (The Analytical Scientist) Grants & Advising: While specific grants are not detailed here, his extensive awards reflect sustained funding and mentorship in proteomics. His lab collaborates on high-impact projects in structural biology and disease research. Labs & Teams: His laboratory (website: [provided link]) is a leader in proteomic tool development, with interdisciplinary collaborations across Scripps Research and global institutions.

Arne KlunglandView profile

Professor

• Epigenetics
• Epitranscriptomics
• DNA Repair
• +7 more

Arne Klungland is a Professor and Centre Director at the Centre for Embryology and Healthy Development (CRESCO), affiliated with the University of Oslo and Oslo University Hospital. His research spans molecular biology, epigenetics, DNA repair, and embryology, with a focus on RNA modifications such as m6A and m1A methylation. University: University of Oslo School: Faculty of Medicine Department: Centre for Embryology and Healthy Development (CRESCO) Academic Rank: Professor Email: arne.klungland@medisin.uio.no His research interests include epigenetics, epitranscriptomics, DNA repair, meiosis, and embryology. His work investigates how RNA modifications regulate gene expression during development and disease, particularly in gametogenesis, stem cell biology, and cancer. He has made significant contributions to understanding m6A and m1A dynamics in mammalian systems. The recent articles highlight a strong trend in RNA epigenetics, particularly m6A and m1A modifications in embryonic development, stem cells, and cancer. His research integrates high-throughput sequencing, molecular biology, and functional genomics to explore post-transcriptional regulation in development and disease. Scientific awards are not mentioned in the provided text. Klungland leads a dynamic research group at CRESCO, mentoring students and postdoctoral researchers. He has been involved in numerous collaborative research projects on DNA repair, RNA modifications, and developmental biology. His lab utilizes advanced techniques such as single-cell RNA mapping, ChIP, and functional assays in mouse and human models. While specific grant details are not listed, his consistent publication in top journals indicates sustained funding and research activity. He leads the Centre for Embryology and Healthy Development (CRESCO), a multidisciplinary research center focused on understanding molecular mechanisms of embryogenesis, fertility, and developmental disorders. The center fosters collaboration between basic scientists and clinicians to translate findings into improved reproductive health outcomes.

• Immunology
• Microbiology
• Infectious Diseases
• +5 more

Dr. Kate Miller is a Senior Lecturer in Microbiology and Immunology at James Cook University (JCU), within the College of Medicine and Dentistry. She holds an affiliation with the Australian Institute of Tropical Health and Medicine. Her academic journey includes a PhD from the Australian National University (1992) focusing on drug resistance in sheep liver fluke, followed by postdoctoral research at The University of Queensland and the University of Technology Sydney. Her current teaching responsibilities include Immunology and Microbiology courses for dental students. Dr. Miller’s research spans parasitology, inflammation biology, and dental biomaterials. Key interests include understanding host-parasite interactions, inflammatory mechanisms in dental implants (osseointegration), and developing novel anti-inflammatory therapies. Recent work explores the microbiome of preterm infants and the application of advanced materials for bone tissue engineering. Her publication trends reveal a focus on dental materials science (e.g., zirconia composites), microbiome analysis (preterm infant gut studies), and immunological assays (T-cell stimulation protocols). Collaborative projects include investigations into probiotic efficacy in neonates and the optimization of antimicrobial strategies for periodontitis. Dr. Miller’s work often bridges basic science and clinical applications, with interdisciplinary collaborations in immunology, microbiology, and engineering. She actively contributes to JCU’s research initiatives and dental education programs.

Alika K. MaunakeaView profile

Professor

• Epigenetics
• Gene-Environment Interactions
• Health Disparities
• +6 more

Alika K. Maunakea, PhD, is a Professor in the Department of Anatomy, Biochemistry & Physiology at the John A. Burns School of Medicine, University of Hawaii. A Native Hawaiian born in Waiʻanae, Hawaiʻi, he earned his B.Sc. in Biology from Creighton University (2001) and PhD in Biomedical Sciences from University of California, San Francisco (2008), followed by postdoctoral training at the National Institutes of Health (2012). His research focuses on epigenetics, particularly DNA methylation and histone modifications, to elucidate gene-environment interactions in health disparities such as diabetes and neurodevelopmental conditions among Native Hawaiian and Pacific Islander (NHPI) populations. Education: Creighton University (B.Sc. Biology), University of California, San Francisco (PhD Biomedical Sciences) Dr. Maunakea integrates multi-omic approaches (epigenomics, microbiome, transcriptomics) with community-engaged research to identify early disease biomarkers and address NHPI health inequities. He directs the Epigenomics Core Facility of Hawaii and the NIH COBRE-funded Consortium of Research Advancement Facilities and Training (CRAFT), and leads studies like the Hawaiʻi Social Epigenomics of Early Diabetes (HI-SEED.org) and Maui Wildfire Exposure Study (www.mauiwes.info). His work on the NIH-funded RADxUP initiative established Hawaii's first CLIA-certified molecular diagnostics lab at a Federally Qualified Health Center serving NHPI communities. His publications span epigenetic mechanisms in autism, diabetes, HIV-related insulin resistance, and SARS-CoV-2 sequelae, with methodology innovations in DNA methylation analysis and next-generation sequencing. He mentors underrepresented minority students in multidisciplinary research careers and collaborates with clinical, behavioral, and economic researchers. Key grants include NIH R01 for HI-SEED.org and multiple NIH grants supporting his career. Current affiliations include graduate faculty roles in the Departments of Molecular Biosciences and Bioengineering, Public Health Studies, Developmental and Reproductive Biology, and Cell and Molecular Biology, with leadership in neuroscience and cancer biology programs.

• Epigenetics
• Developmental Biology
• Molecular Biology
• +3 more

Dr Adrienne Sullivan is a Group Leader at the Adelaide Centre for Epigenetics within the School of Biomedicine at the University of Adelaide. She leads the Development and Epigenetics Lab, focusing on understanding epigenetic mechanisms controlling gene enhancers during cellular differentiation and disease. Her work bridges developmental biology and oncology, examining how epigenetic remodeling influences cell identity and contributes to cancer drug resistance. Dr Sullivan is eligible to supervise Masters and PhD students in these areas. Research Interests: Epigenetic regulation of gene enhancers Cell fate determination during mammalian development Molecular basis of obesity and metabolic disorders 3D genome organization and nuclear architecture Functional genomics and epigenetic profiling techniques Publications highlight her expertise in developmental epigenetics (gastruloid models), obesity genetics (SIM1 variants), and molecular biology techniques (loopometer assay). Though no awards are explicitly mentioned, her active research profile indicates significant contributions to these fields.

• Cancer Biology
• Molecular Biology
• Epigenetics
• +6 more

Veronica De Sanctis is a Staff Scientist and Head of the Next Generation Sequencing Core Facility at CIBIO, Università di Trento, Italy, since 2011. She leads genomic sequencing initiatives, protocol development, and technical support for research projects. Her academic career includes postdoctoral research at UCLA (2005–2007) under Michael Grunstein, focusing on chromatin structure and transcriptional regulation, and at Università di Roma 'La Sapienza' (2003–2005). She earned a PhD in Genetics and Molecular Biology from Rome, with a thesis on Saccharomyces cerevisiae transcriptional regulation. Her research expertise spans epigenetics, gene expression regulation, and genomic technologies. Key areas include histone modifications, miRNA regulation, and NGS applications in cancer and microbiome studies. She has contributed to projects on p53 pathways, CRISPR-Cas9 editing, and SARS-CoV-2 diagnostics. Publications highlight her work on cancer genomics, epigenetic mechanisms, and microbiome analysis. She has developed methods for miRNA detection and optimized NGS workflows. Her professional memberships include the CTLS Core Technologies for Life Science (2020–present) and SIGU (2013–2019).

Manuel Maria Paz CastañalView profile

Professor

• Organic Chemistry
• Bioactive Compounds Synthesis
• Catalysis
• +3 more

Manuel Maria Paz Castañal is a Professor in the Department of Organic Chemistry at the University of Santiago de Compostela's Faculty of Chemistry. As a member of the COBINMA research group and affiliated with the Institute of Materials (iMATUS) and Strategic Grouping in Materials (AEMAT), he specializes in the synthesis of bioactive compounds, drug development, and molecular toxicology of anticancer agents like mitomycins. Education: PhD in Organic Chemistry (1994) from University of Santiago de Compostela Résumé: Thesis on asymmetric synthesis of biologically relevant compounds Research Focus: His work combines organic synthesis with biomedical applications, particularly examining mitomycin C's DNA crosslinking mechanisms and creating nanoparticle-drug conjugates for enhanced cancer therapy. His studies span reaction mechanisms, stereochemical control, and drug-biomolecule interactions. Publication Trends: Recent research highlights mitomycin-DNA adducts, nanoparticle drug delivery systems, and redox activation pathways, with significant contributions to understanding sequence selectivity and stereochemical configurations in DNA damage. Collaborations: Active in interdisciplinary research networks, including Reactivity and Catalysis (ReactyCat) and pharmaceutical R&D (GI-1606) groups.

• Bioinformatics
• Transcriptomics
• Gene Expression Analysis
• +4 more

David Philip Kreil is an Associate Professor at the Institute of Molecular Biotechnology within the Department of Biotechnology and Food Science at the University of Natural Resources and Life Sciences, Vienna (BOKU) . He holds a joint appointment as Chair of Bioinformatics at the University of Warwick (2012-2014) and has held research positions at the European Bioinformatics Institute (EBI) and the University of Cambridge . His work bridges computational biology, transcriptomics, and plant-nematode interactions. 2012-2014: Chair of Bioinformatics, University of Warwick 2005: WWTF Vienna Science Chair at BOKU 2001-2004: MRC Research Fellow, University of Cambridge 1997-2001: EMBL PhD Programme, EBI Kreil's research focuses on transcriptomic analysis of plant-pathogen interactions (e.g., Fusarium resistance in wheat, nematode-induced syncytia) and computational methods for microarray calibration, data normalization, and statistical modeling. He has applied machine learning to weather forecasting and biomedical data. Scientific Awards : Research Fellow, Darwin College, University of Cambridge (2002-2005) His 15 most recent articles emphasize bioinformatics tools, plant immunity, and interdisciplinary applications of machine learning in biology and climate science. He has supervised theses on wheat transcriptomics and nematode-induced gene expression.

Claudia ChicaView profile

Researcher

• Epigenomics
• Chromatin Analysis
• Computational Biology
• +3 more

Claudia Chica is a Senior Bioinformatician at the Bioinformatics and Biostatistics HUB of Institut Pasteur in Paris, France, where she has been working since October 2015. Her research focuses on computational analysis of epigenomic and transcriptomic data, with particular expertise in chromatin profiling techniques including ChIP-seq, ATAC-seq, and RNA-seq. Her research interests span epigenomics, chromatin analysis, single-cell data analysis, and bioinformatics tool development. She has made significant contributions to understanding chromatin dynamics in immune memory, bacterial pathogenesis, and plant genome evolution. Her methodological expertise includes statistical modeling for high-throughput sequencing data and integration of multi-omics datasets. Dr. Chica's recent publications demonstrate a strong focus on epigenomic mechanisms underlying immune memory in bronchial epithelial cells, bacterial virulence evolution, and development of bioinformatics tools like ePeak and SCHNAPPs for epigenomic and single-cell data analysis. Her work bridges computational methodologies with biological discovery across diverse systems from human immunology to plant genomics. She has been actively involved in teaching and training researchers, having co-organized multiple bioinformatics courses at Institut Pasteur, including the Bioinformatics program for PhD students and specialized courses on high-throughput sequencing data analysis, comparative genomics, and functional omics.